Signaling Pathways - Reversible - Cancer
清除全部
- C3342 MAZ51Target: VEGFRSummary: VEGFR3拮抗剂
- B5881 RI-2Target: RAD51Summary: RAD51抑制剂
- A8885 Ro 33064 CitationTarget: Cyclin-Dependent KinasesSummary: CDK1抑制剂
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂
- B1255 AZ505Target: SMYD2Summary: SMYD2抑制剂
- B2176 GSK1059615Target: PI3K|mTORSummary: PI3K和mTOR抑制剂
- A8487 Nocodazole1 Citation中文名: 诺考达唑Target: Microtubules/TubulinsSummary: 微管蛋白产生抑制剂,抗肿瘤剂
- A8441 GSK4613643 CitationTarget: PLKSummary: Plk1抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8375 AZD8931 (Sapitinib)中文名: 沙普替尼Target: EGFR|ErbBSummary: ErbB抑制剂